DK528386A - Proteinabsorptionsforoegende midler - Google Patents

Proteinabsorptionsforoegende midler

Info

Publication number: DK528386A
Authority: DK; Denmark
Prior art keywords: protein absorption; preparing agents; absorption preparing; agents; protein
Prior art date: 1985-03-06

Application number

DK528386A

Other languages

English (en)

Other versions

DK528386D0 (da

Inventor

Stanley Jay Sarnoff

Burton E Sobel

Original Assignee

Survival Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-06

Filing date

1986-11-05

Publication date

1986-11-05

1985-03-06 Priority claimed from US06/708,845 external-priority patent/US4661469A/en

1985-10-01 Priority claimed from US06/782,441 external-priority patent/US4772585A/en

1986-11-05 Application filed by Survival Technology filed Critical Survival Technology

1986-11-05 Publication of DK528386D0 publication Critical patent/DK528386D0/da

1986-11-05 Publication of DK528386A publication Critical patent/DK528386A/da

Links

238000010521 absorption reaction Methods 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
230000007721 medicinal effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK528386A 1985-03-06 1986-11-05 Proteinabsorptionsforoegende midler DK528386A (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US06/708,845 US4661469A (en)	1984-08-08	1985-03-06	t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A	1985-03-27	1985-03-27
US06/782,441 US4772585A (en)	1984-08-08	1985-10-01	Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en)	1985-03-06	1986-03-06	Protein absorption enhancing agents

Publications (2)

Publication Number	Publication Date
DK528386D0 DK528386D0 (da)	1986-11-05
DK528386A true DK528386A (da)	1986-11-05

Family

ID=27418848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK528386A DK528386A (da)	1985-03-06	1986-11-05	Proteinabsorptionsforoegende midler

Country Status (9)

Country	Link
EP (1)	EP0214281B1 (da)
AT (1)	ATE80306T1 (da)
AU (1)	AU593794B2 (da)
DE (1)	DE3686684T2 (da)
DK (1)	DK528386A (da)
FI (1)	FI864480L (da)
HU (1)	HUT41632A (da)
NO (1)	NO864382D0 (da)
WO (1)	WO1986005096A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839170A (en) *	1985-10-01	1989-06-13	Survival Technology, Inc.	Protein absorption enhancing agents
DE3544663A1 (de) *	1985-12-13	1987-06-19	Schering Ag	Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK175380B1 (da) *	1985-04-22	2004-09-20	Genentech Inc	Mutant af human vævsplasminogenaktivator, DNA-sekvens som koder herfor, replicerbar udtrykkelsesvektor til at udtrykke denne DNA-sekvens, mikroorganisme transformeret med denne vektor, cellekulturer transformeret med denne....
AU569429B2 (en) *	1985-05-28	1988-01-28	Wellcome Foundation Limited, The	Aqueous acidic tissue plasminogen activator parenternal formulation

1986
- 1986-03-06 WO PCT/US1986/000475 patent/WO1986005096A1/en not_active Ceased
- 1986-03-06 EP EP86902132A patent/EP0214281B1/en not_active Expired - Lifetime
- 1986-03-06 AT AT86902132T patent/ATE80306T1/de not_active IP Right Cessation
- 1986-03-06 DE DE8686902132T patent/DE3686684T2/de not_active Expired - Fee Related
- 1986-03-06 FI FI864480A patent/FI864480L/fi not_active Application Discontinuation
- 1986-03-06 HU HU863035A patent/HUT41632A/hu unknown
- 1986-03-06 AU AU55811/86A patent/AU593794B2/en not_active Ceased
- 1986-11-03 NO NO864382A patent/NO864382D0/no unknown
- 1986-11-05 DK DK528386A patent/DK528386A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
FI864480A0 (fi)	1986-11-04
DK528386D0 (da)	1986-11-05
DE3686684T2 (de)	1993-01-28
NO864382L (no)	1986-03-11
EP0214281A1 (en)	1987-03-18
FI864480A7 (fi)	1986-11-04
WO1986005096A1 (en)	1986-09-12
DE3686684D1 (de)	1992-10-15
NO864382D0 (no)	1986-11-03
EP0214281A4 (en)	1989-03-16
AU593794B2 (en)	1990-02-22
FI864480L (fi)	1986-11-04
ATE80306T1 (de)	1992-09-15
AU5581186A (en)	1986-09-24
EP0214281B1 (en)	1992-09-09
HUT41632A (en)	1987-05-28

Similar Documents

Publication	Publication Date	Title
DE3587941D1 (de)	1994-12-01	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3687741D1 (de)	1993-03-25	Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
NO833769L (no)	1984-04-24	Immunogent protein- eller peptidkompleks, fremgangsmaate for fremstilling og anvendelse herav som immunstimulerende middel og som vaksine
FI875533L (fi)	1987-12-16	Insulinpreparat foer non-parenteral dosering.
IL80020A0 (en)	1986-12-31	Antibody complexes of hapten-modified diagnostic or therapeutic agents
DK614987D0 (da)	1987-11-23	Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
JPS5231839A (en)	1977-03-10	Drug for cosmetics and permanent wave in combination
DK528386A (da)	1986-11-05	Proteinabsorptionsforoegende midler
DE69523055D1 (de)	2001-11-08	T-zellen stimulierendes protein von pestivirus
ATE61522T1 (de)	1991-03-15	Pharmazeutische zubereitung zur behandlung von tinea pedis.
FI92716C (fi)	1994-12-27	Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
IL76121A0 (en)	1985-12-31	Protein absorption enhancing agents
FI885025A0 (fi)	1988-11-01	Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
SE8402199L (sv)	1984-10-23	Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
DE3873825D1 (de)	1992-09-24	Die proteinabsorption verbessernde stoffe.
FI834429A7 (fi)	1984-06-04	3',5'-diarabinosidien valmistus ja terapeuttinen soveltaminen.
DK333476A (da)	1977-01-26	2-chlor-n-isopropyl-2',3'-dimethylacetanilid samt dets fremstilling og anvendelse
IT8822558A0 (it)	1988-11-09	Soluzione farmaceutica acquosa per uso oftalmico.
NO872633D0 (no)	1987-06-23	Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
IT8349430A0 (it)	1983-12-02	Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici
ES522243A0 (es)	1984-08-01	Procedimiento para la preparacion de mezclas de liquidos farmaceuticos,particularmente soluciones de infusion
IT8819879A0 (it)	1988-03-22	Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
BR6802052U (pt)	1990-05-01	Mascara cirurgica descartavel retangular com cadarcos costurados pelo sistema hrow(hight resfst one way)
DK381787D0 (da)	1987-07-21	Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
IT208775Z2 (it)	1988-05-28	Siringa per l'anestesia intraligamentosa.

Legal Events

Date	Code	Title	Description
1990-11-26	AHB	Application shelved due to non-payment